Treatment related damage in the ANCA-associated vasculitides: An analysis of cohorts from the European Vasculitis Study Group (EUVAS) therapeutic trials - 26/03/13
Doi : 10.1016/j.lpm.2013.02.221
J. Robson 1, H. Doll 2, O. Flossmann 3, S. Ravi 4, H. Lorraine 5, H. Peter 6, J. David 7, M. Chetan 8, W. Kerstin 6, L. Raashid 1
1 University of Oxford, Oxford, United Kingdom
2 University of East Anglia, Norwich, United Kingdom
3 Royal Berkshire Hospital, Reading, United Kingdom
4 Auckland DHB, Auckland, New Zealand
5 University of Birmingham, Birmingham, United Kingdom
6 Lund University, Lund, Sweden
7 Addenbrook’s Hospital, Cambridge, United Kingdom
8 Norfolk and Norwich University Hospital, Norwich, United Kingdom
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.
Si connetta per beneficiarne
Il testo completo di questo articolo è disponibile in PDF.
Mappa
© 2013
Pubblicato da Elsevier Masson SAS.
Vol 42 - N° 4P2
P. 744-745 - Aprile 2013 Ritorno al numero
Articolo precedente
- Long-term outcomes of patients with Reversible Cerebral Vasoconstriction Syndrome (RCVS)
- S. John, L. Calabrese, K. Uchino, S. Tepper, M. Stillman, R. Hajj-Ali
- Factors associated with long-term damage in the ANCA-associated vasculitides: An analysis of cohorts from the European vasculitis study group (EUVAS) therapeutic trials
- J. Robson, H. Doll, F. Oliver, S. Ravi, H. Lorraine, H. Peter, J. David, M. Chetan, W. Kerstin, L. Raashid
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.